Colorectal Cancer: Early Detection and Routine Screening
March 11, 2019
Colon Cancer, Early Detection and The Importance of Routine Screening
Colorectal cancer is the fourth most commonly diagnosed cancer among adults in the United States. Currently, the U.S. Preventive Services Task Force (USPSTF) recommends routine screening for adults ages 50 to 75.
However, the American Cancer Society recently modified their recommendation to begin at age 45 for those with average risk. The guideline was changed based in part on new data showing increased rates of colorectal cancer in younger populations.
Companies like Clinical Genomics are focused on improving the sensitivity and accuracy of screening tests, as well as providing options that may lead to early detection of residual and recurrent colorectal cancer in patients who have undergone primary treatment.
We get the facts from Dr. Roberto Rodriguez-Ruesga, a colon and rectal surgeon at Texas Oncology, and hear one woman’s personal story of being diagnosed with colon cancer at only 43 years old.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.